The phase III VICTORIA trial of vericiguat, an investigational drug for patients worsening chronic heart failure and reduced ejection fraction, met its primary endpoint, drugmakers Merck and Bayer AG announced on Monday.
LONDON, England—Follow-up data from the PORTICO I study testing the self-expanding Portico transcatheter heart valve (Abbott) show a low rate of cardiovascular mortality and disabling stroke at 2 years, as well as continued low transvalvular gradients and large valve areas.
PHILADELPHIA, PA—Physicians shouldn’t be too hasty about dropping aspirin in all A-fib patients after PCI, as it appears those with a particularly high risk of stent thrombosis might benefit from up to 1 month of additional coverage, an analysis of the AUGUSTUS trial suggests.
Women are more likely than men to experience stroke while hospitalized for PCI, 14 years’ worth of US registry data confirm.
Compared with other types of complex PCI, chronic total occlusion (CTO) PCI is less often associated with procedural success and carries a higher risk of complications such as coronary perfusion and tamponade, according to a single-center analysis. However, the rates of other in-hospital and long-term adverse events are similar.
I had a funny dream the other night. I was somehow supposed to be the lead discussant at the upcoming American Heart Association (AHA) Scientific Sessions on the ISCHEMIA trial results, except there was a problem.
Lipid and lipoprotein levels have declined in the United States since the publication of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines, specifically among people who were taking lipid-lowering therapy, according to a new analysis from the National Health and Nutrition Examination Survey (NHANES).
The Centers for Medicare & Medicaid Services (CMS) has rendered its final rule regarding 2020 reimbursement rates associated with cardiac computed tomography performed in hospitals, and imagers are not happy.
The US Food and Drug Administration has designated Abbott’s recent recall of the CentriMag circulatory support system motor as Class I, the most serious type.
Patients who are undergoing transvenous lead extraction for a device-related infection have particularly high rates of complications and mortality during the initial hospital stay, new national US data show.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!